Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Kalyan Roy: Immunomodulation after Blood Transfusion
Kalyan Roy/ LinkedIn
Jun 6, 2026, 17:39

Kalyan Roy: Immunomodulation after Blood Transfusion

Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:

“Immunomodulation After Blood Transfusion

Understanding Transfusion-Related Immunomodulation (TRIM)

Blood transfusion is one of the most important life-saving interventions in modern medicine.

However, beyond replacing red cells, platelets, or plasma, transfusion can also influence the recipient’s immune system—a phenomenon known as

Transfusion-Related Immunomodulation (TRIM).

What is TRIM?

TRIM refers to the complex immunological changes that occur following transfusion of allogeneic blood products.

These changes may result in:

  • Immune suppression
  • Immune activation
  • Immune tolerance
  • Altered cytokine responses
  • Modulation of T-cell and NK-cell function
  • Key Mechanisms Behind TRIM
  • Allogeneic Leukocyte Exposure
  • Interaction with recipient immune cells
  • T-cell anergy induction
  • Regulatory T-cell (Treg) expansion
  • Soluble Bioactive Mediators
  • IL-1β, IL-6, IL-8, TNF-α
  • Soluble HLA molecules
  • Fas Ligand (FasL)
  • TGF-β
  • Microchimerism
  • Persistence of donor leukocytes in recipients
  • Promotion of immune tolerance
  • Long-term immunological alterations
  • Th1 → Th2 Immune Shift
  • Reduced cell-mediated immunity
  • Enhanced immunosuppressive pathways
  • Effects on Innate Immunity
  • Reduced neutrophil chemotaxis and phagocytosis
  • Altered monocyte/macrophage function
  • Decreased Natural Killer (NK) cell activity
  • Reduced tumor immune surveillance
  • Effects on Adaptive Immunity
  • Reduced T-cell proliferation
  • Increased T-cell apoptosis
  • Expansion of regulatory T-cell populations
  • Altered antibody production and humoral immunity
  • Potential Clinical Consequences
  • Increased susceptibility to infections
  • Potential impact on cancer progression and recurrence
  • Increased postoperative morbidity
  • Longer hospital and ICU stays
  • Delayed wound healing
  • Possible influence on autoimmune responses

Can Leukoreduction Eliminate TRIM?

While universal leukoreduction significantly reduces:

  • Febrile non-hemolytic transfusion reactions
  • HLA alloimmunization
  • CMV transmission

It does not completely eliminate TRIM, as storage-related bioactive substances and extracellular vesicles may still contribute to immune modulation.

  • How Can We Minimize TRIM?
  • Patient Blood Management (PBM)
  • Restrictive transfusion strategies
  • Appropriate component selection
  • Universal leukoreduction
  • Irradiation when indicated
  • Avoidance of unnecessary transfusions

Take-Home Message

Although blood transfusion remains an indispensable therapeutic tool, understanding its immunological consequences is essential for optimizing patient outcomes and advancing transfusion safety.

Every unit transfused carries not only oxygen and hemostatic support—but also potential immunological effects that deserve careful consideration.”

Kalyan Roy

Stay updated with Hemostasis Today.

Health Hematology Hemostasis Hemostasis News Hemostasis Today Kalyan Roy Medicine
NewsFeed